PORTAGE BIOTECH INC
(NASDAQ: PRTG)
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
0.563
+0.023
(+4.26%)
Range
- - -
(-%)
Open
0.571
Previous Close
0.540
Bid Price
3.230
Bid Volume
12
Ask Price
3.240
Ask Volume
9
Volume
17,067
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis